Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease

NCT03817840 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03817840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03817840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease
Lead sponsor
Columbia University
Phase
Observational
Overall status
Completed
Start date
July 16, 2018
Completion date
July 1, 2021
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cushing's syndrome